Cannabics Pharmaceuticals Announces Launch of WanaCaps XR

Cannabics Pharmaceuticals Inc. (OTCMKTS:CNBX) announced that its strategic partner Wana Products has formally launched “WannaCaps XR,” a series of extended release cannabis capsules that provide beneficial effects for up to multiple hours per dose.

As quoted in the press release:

Cannabics Pharmaceuticals Inc., a U.S. based Bio Tech Development Company with R&D in Israel, developed the unique proprietary technology behind the extended release formulation and licenses this technology to Wana. Cannabics chose Wana over all other licensed Colorado Medicinal Edible manufacturers due to their high quality control standards and professionalism in their business ethics.

WanaCapsxr will be offered in three different formulations: capsules with a 10:1 CBD to THC ratio (WanaCapsxr High CBD Capsules), a 10:1 THC to CBD ratio (WanaCapsxr High THC Capsules), and a balanced formulation with 1:1 THC:CBD ratio (WanaCapsxr THC/CBD Balanced Capsules). Each package of WanaCapsxr contains ten 10 mg capsules, allowing for precise dosing based on the patient’s individual needs and tolerance.

Nancy Whiteman, co-owner of Wana Products, commented:

The extended release formulation enables patients to dose once or twice daily so they can get on with their lives without the constant need to be thinking about re-dosing. Additionally the new capsules also address one of the major concerns of cannabis patients, which is that the initial high peak of cannabinoid activity soon after administration which can cause uncomfortable side effects such as disorientation and dizziness. Instead, with WanaCapsxr, patients experience a long-lasting, stable effect without the ups and downs.

Dr. Eyal Ballan, chief scientist of Cannabics Pharmaceuticals, commented:

Cannabics researchers are making breakthroughs in the medical evolution of cannabis, and WanaCapsxr is on the leading edge of those advancements. Wana’s new XR product will help legal medical marijuana states approach the roll out of medical cannabis in a new, controlled, stable and effective way.

Click here to read the full Cannabics Pharmaceuticals Inc. (OTCMKTS:CNBX) press release.